790 related articles for article (PubMed ID: 9267721)
1. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy.
Cantarovich M; Latter DA; Loertscher R
Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721
[TBL] [Abstract][Full Text] [Related]
2. How successful is OKT3 rescue therapy for steroid-resistant acute rejection episodes after heart transplantation?
Wagner FM; Reichenspurner H; Uberfuhr P; Kur F; Kaulbach HG; Meiser BM; Ziegler U; Reichart B
J Heart Lung Transplant; 1994; 13(3):438-42; discussion 442-3. PubMed ID: 8061020
[TBL] [Abstract][Full Text] [Related]
3. Induction therapy with cyclosporine without cytolytic agents results in a low incidence of acute rejection without significant renal impairment in heart transplant patients.
Jazzar A; Fagiuoli S; Sisson S; Zuhdi N; Cooper DK
Clin Transplant; 1995 Aug; 9(4):334-9. PubMed ID: 7579743
[TBL] [Abstract][Full Text] [Related]
4. Treatment of renal allograft acute rejection with methylprednisolone: effect of fixed dose versus dose per body mass index.
Douzdjian V; Rice JC; Gugliuzza KK; Fisch JC; Carson RW
Clin Transplant; 1996 Jun; 10(3):310-5. PubMed ID: 8826672
[TBL] [Abstract][Full Text] [Related]
5. Use of OKT3 is associated with early and severe recurrence of hepatitis C after liver transplantation.
Rosen HR; Shackleton CR; Higa L; Gralnek IM; Farmer DA; McDiarmid SV; Holt C; Lewin KJ; Busuttil RW; Martin P
Am J Gastroenterol; 1997 Sep; 92(9):1453-7. PubMed ID: 9317061
[TBL] [Abstract][Full Text] [Related]
6. Sequential biological immunosuppression. Induction therapy with rabbit antithymocyte globulin.
Guttmann RD; Flemming C
Clin Transplant; 1997 Jun; 11(3):185-92. PubMed ID: 9193840
[TBL] [Abstract][Full Text] [Related]
7. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients.
Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW
J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608
[TBL] [Abstract][Full Text] [Related]
8. Induction immunosuppressive therapy is associated with a low rejection rate after liver transplantation.
McVicar JP; Kowdley KV; Emond MJ; Barr D; Marsh CL; Carithers RL; Perkins JD
Clin Transplant; 1997 Aug; 11(4):328-33. PubMed ID: 9267724
[TBL] [Abstract][Full Text] [Related]
9. [Kidney-pancreas transplantation. Clinical results in 23 consecutive patients].
Maestri M; Krieger N; Kuo P; Dafoe DC; Alfrey EJ
Minerva Chir; 1998 Mar; 53(3):121-8. PubMed ID: 9617106
[TBL] [Abstract][Full Text] [Related]
10. HLA-DR incompatibility predicts heart transplant rejection independent of immunosuppressive prophylaxis.
Costanzo-Nordin MR; Fisher SG; O'Sullivan EJ; Johnson M; Heroux A; Kao W; Mullen GM; Radvany R; Robinson J
J Heart Lung Transplant; 1993; 12(5):779-89. PubMed ID: 8241215
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of OKT3 therapy for acute rejection in isolated lung transplantation.
Shennib H; Massard G; Reynaud M; Noirclerc M
J Heart Lung Transplant; 1994; 13(3):514-9. PubMed ID: 8061029
[TBL] [Abstract][Full Text] [Related]
12. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
[TBL] [Abstract][Full Text] [Related]
13. OKT3 escalating dose regimens provide effective therapy for renal allograft rejection.
Woodle ES; Bruce DS; Josephson M; Cronin D; Newell KA; Millis JM; Piper JB; O'Laughlin R; Thistlethwaite JR
Clin Transplant; 1996 Aug; 10(4):389-95. PubMed ID: 8884115
[TBL] [Abstract][Full Text] [Related]
14. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular dysfunction after heart transplantation: incidence and role of enhanced immunosuppression.
McNamara D; Di Salvo T; Mathier M; Keck S; Semigran M; Dec GW
J Heart Lung Transplant; 1996 May; 15(5):506-15. PubMed ID: 8771506
[TBL] [Abstract][Full Text] [Related]
16. A randomized prospective trial of prophylactic immunosuppression with ATG-fresenius versus OKT3 after renal transplantation.
Bock HA; Gallati H; Zürcher RM; Bachofen M; Mihatsch MJ; Landmann J; Thiel G
Transplantation; 1995 Mar; 59(6):830-40. PubMed ID: 7701577
[TBL] [Abstract][Full Text] [Related]
17. A randomized prospective study comparing low-dose OKT3 to low-dose ATG for the treatment of acute steroid-resistant rejection episodes in kidney transplant recipients.
Mariat C; Alamartine E; Diab N; de Filippis JP; Laurent B; Berthoux F
Transpl Int; 1998; 11(3):231-6. PubMed ID: 9638854
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate for rejection prophylaxis after heart transplantation.
Taylor DO; Olsen SL; Ensley RD; Renlund DG
J Heart Lung Transplant; 1995; 14(5):950-4. PubMed ID: 8800732
[TBL] [Abstract][Full Text] [Related]
19. Management of acute rejection of kidney allograft.
Yu LX; Jia YB; Zhang Y
Di Yi Jun Yi Da Xue Xue Bao; 2002 Aug; 22(8):752-4. PubMed ID: 12376272
[TBL] [Abstract][Full Text] [Related]
20. Treatment of recalcitrant cardiac allograft rejection with methotrexate. Cardiac Transplant Team.
Chan GL; Weinstein SS; Vijayanagar RR
Clin Transplant; 1995 Apr; 9(2):106-14. PubMed ID: 7599398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
